T. Rowe Price Associates’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Hold |
1,071,550
| – | – | ﹤0.01% | 1086 |
|
|
2025
Q1 | $12.1M | Sell |
1,071,550
-16,221
| -1% | -$183K | ﹤0.01% | 1074 |
|
|
2024
Q4 | $11.4M | Sell |
1,087,771
-39,827
| -4% | -$418K | ﹤0.01% | 1127 |
|
|
2024
Q3 | $11.8M | Sell |
1,127,598
-3,079
| -0.3% | -$32.2K | ﹤0.01% | 1111 |
|
|
2024
Q2 | $11.6M | Hold |
1,130,677
| – | – | ﹤0.01% | 1087 |
|
|
2024
Q1 | $11.7M | Buy |
+1,130,677
| New | +$11.7M | ﹤0.01% | 1076 |
|